V, B., SY, T., M, H., Y, Z., & S, D. (2025). Experimental design considerations and statistical analyses in preclinical tumor growth inhibition studies. Pharmaceutical statistics, 24(1), e2399. https://doi.org/10.1002/pst.2399
Chicago Style (17th ed.) CitationV, Bonato, Tang SY, Hsieh M, Zhang Y, and Deng S. "Experimental Design Considerations and Statistical Analyses in Preclinical Tumor Growth Inhibition Studies." Pharmaceutical Statistics 24, no. 1 (2025): e2399. https://doi.org/10.1002/pst.2399.
MLA (9th ed.) CitationV, Bonato, et al. "Experimental Design Considerations and Statistical Analyses in Preclinical Tumor Growth Inhibition Studies." Pharmaceutical Statistics, vol. 24, no. 1, 2025, p. e2399, https://doi.org/10.1002/pst.2399.